NHS Dudley Health Economy Medicines Formulary
Home > 8 Malignant disease and immunosuppression > 8.1 Cytotoxic drugs > 8.1.5 Other antineoplastic drugs > Pembrolizumab for advanced melanoma not previously treated with ipilimumab - NICE TAG TA366

Pembrolizumab for advanced melanoma not previously treated with ipilimumab - NICE TAG TA366

1.1 Pembrolizumab is recommended as an option for treating advanced (unresectable or metastatic) melanoma that has not been previously treated with ipilimumab, in adults, only when the company provides pembrolizumab with the discount agreed in the patient access scheme.

 

https://www.nice.org.uk/guidance/ta366

Site by Devopa
© Copyright 2019 NHS. All rights reserved.